See more : Rugby Resources Ltd. (RUG.V) Income Statement Analysis – Financial Results
Complete financial analysis of RBC Life Sciences, Inc. (RBCL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of RBC Life Sciences, Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Tellgen Corporation (300642.SZ) Income Statement Analysis – Financial Results
- Misawa & Co.,Ltd. (3169.T) Income Statement Analysis – Financial Results
- Core Assets Corp. (CCOOF) Income Statement Analysis – Financial Results
- Proton Motor Power Systems PLC (P6K0.DE) Income Statement Analysis – Financial Results
- Indigo Paints Limited (INDIGOPNTS.BO) Income Statement Analysis – Financial Results
RBC Life Sciences, Inc. (RBCL)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.rbclifesciences.com
About RBC Life Sciences, Inc.
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.
| Metric | 2022 | 2021 | 2020 | 2019 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 25.77M | 24.37M | 28.27M | 25.47M | 25.16M | 28.45M | 28.16M | 24.92M | 30.41M | 27.03M | 21.70M | 19.36M | 18.27M | 19.28M | 26.28M | 34.62M | 39.99M | 34.19M | 27.19M | 14.05M | 2.02M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 12.16M | 10.90M | 12.63M | 13.46M | 12.53M | 14.13M | 14.47M | 12.12M | 14.91M | 12.13M | 8.58M | 7.47M | 6.56M | 5.91M | 8.43M | 10.53M | 11.54M | 8.75M | 7.10M | 3.78M | 348.27K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 13.61M | 13.46M | 15.64M | 12.01M | 12.63M | 14.32M | 13.69M | 12.80M | 15.49M | 14.90M | 13.12M | 11.89M | 11.70M | 13.37M | 17.85M | 24.09M | 28.45M | 25.45M | 20.09M | 10.27M | 1.68M |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 52.82% | 55.25% | 55.32% | 47.16% | 50.21% | 50.32% | 48.61% | 51.36% | 50.95% | 55.12% | 60.46% | 61.39% | 64.08% | 69.34% | 67.93% | 69.58% | 71.14% | 74.42% | 73.89% | 73.09% | 82.79% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 13.87M | 11.28M | 11.06M | 9.34M | 9.81M | 9.63M | 9.23M | 10.06M | 10.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 536.65K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 4.12M | 4.19M | 4.70M | 2.79M | 3.21M | 4.31M | 2.94M | 2.50M | 2.29M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36M |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 13.87M | 15.47M | 15.76M | 12.13M | 13.02M | 13.95M | 12.17M | 12.56M | 12.31M | 11.67M | 11.54M | 10.44M | 10.47M | 12.66M | 17.10M | 22.86M | 11.46M | 10.38M | 8.08M | 5.28M | 1.89M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 14.28M | 15.97M | 16.26M | 12.64M | 13.54M | 14.39M | 12.64M | 12.96M | 12.64M | 12.00M | 12.15M | 11.02M | 11.05M | 13.26M | 17.73M | 23.78M | 27.63M | 25.08M | 19.49M | 10.83M | 578.03K |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 26.44M | 26.88M | 28.90M | 26.10M | 26.07M | 28.52M | 27.11M | 25.08M | 27.56M | 24.13M | 20.73M | 18.49M | 17.61M | 19.17M | 26.16M | 34.31M | 39.17M | 33.83M | 26.59M | 14.61M | 926.30K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.50K | 95.72K | 111.62K | 126.33K | 139.96K | 152.56K | 164.24K | 175.06K | 209.77K | 252.18K | 251.47K | 262.12K | 303.67K | 388.48K | 423.68K | 177.31K | 0.00 | 0.00 | 0.00 | 10.64K |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 414.78K | 502.15K | 579.90K | 588.29K | 584.74K | 506.58K | 539.29K | 455.60K | 373.81K | 362.81K | 634.70K | 593.13K | 591.51K | 607.42K | 625.03K | 920.84K | 692.38K | 468.12K | 347.63K | 307.31K | 13.97K |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -251.51K | -302.45K | -45.37K | -36.34K | 121.14K | 435.70K | 1.58M | 295.99K | 3.23M | 3.26M | 1.60M | 1.46M | 1.24M | 720.16K | 467.71K | 1.64M | 1.77M | 36.15M | 28.73M | -256.48K | 249.18K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -0.98% | -8.25% | -0.16% | -0.14% | -1.28% | 1.53% | 5.62% | 1.19% | 10.61% | 12.07% | 7.38% | 7.56% | 5.99% | 4.10% | 3.47% | 6.99% | 41.85% | 2.43% | 3.50% | -1.83% | 54.91% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | -666.28K | -2.51M | -625.27K | -624.62K | -463.59K | -70.89K | 1.04M | -159.62K | 2.85M | 2.90M | 966.29K | 870.22K | 650.97K | 112.73K | 127.97K | 305.64K | 820.18K | 364.47K | 603.21K | -673.92K | 1.10M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -2.59% | -10.31% | -2.21% | -2.45% | -1.84% | -0.25% | 3.71% | -0.64% | 9.38% | 10.72% | 4.45% | 4.49% | 3.56% | 0.58% | 0.49% | 0.88% | 2.05% | 1.07% | 2.22% | -4.80% | 54.22% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.67M | -95.72K | -111.62K | 316.73K | -139.96K | -152.56K | -164.24K | -175.06K | -209.77K | -252.18K | -251.47K | -113.78K | -374.61K | -414.45K | -1.10M | -184.11K | -116.39K | -95.99K | 0.00 | -1.11M |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | -666.28K | -846.10K | -720.99K | -736.24K | -589.93K | -210.84K | 891.21K | -323.85K | 2.68M | 2.69M | 714.12K | 592.05K | 537.19K | -261.88K | -418.86K | -1.31M | 890.97K | 248.08K | 507.22K | -673.92K | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -2.59% | -3.47% | -2.55% | -2.89% | -2.34% | -0.74% | 3.17% | -1.30% | 8.80% | 9.95% | 3.29% | 3.06% | 2.94% | -1.36% | -1.59% | -3.79% | 2.23% | 0.73% | 1.87% | -4.80% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 90.00K | -104.27K | -118.17K | -236.24K | -228.49K | -139.35K | 333.46K | 11.00K | 1.06M | 996.50K | 277.91K | 26.71K | 113.78K | -81.75K | 10.11K | -122.21K | 380.68K | 117.38K | -12.33K | 12.97K | 1.37M |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | -756.28K | -741.84K | -602.81K | -500.01K | -361.44K | -71.49K | 557.75K | -334.85K | 1.62M | 1.69M | 436.20K | 592.05K | 537.19K | -105.32K | -403.57K | -1.19M | 510.29K | 268.27K | 434.87K | -686.88K | -268.82K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -2.93% | -3.04% | -2.13% | -1.96% | -1.44% | -0.25% | 1.98% | -1.34% | 5.31% | 6.26% | 2.01% | 3.06% | 2.94% | -0.55% | -1.54% | -3.44% | 1.28% | 0.78% | 1.60% | -4.89% | -13.29% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.34 | -0.34 | -0.27 | -0.23 | -0.16 | -0.03 | 0.30 | -0.15 | 0.80 | 0.80 | 0.20 | 0.30 | 0.30 | -0.06 | -0.29 | -0.85 | 0.40 | 0.23 | -0.02 | -0.51 | -0.09 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.34 | -0.34 | -0.27 | -0.23 | -0.16 | -0.03 | 0.20 | -0.15 | 0.70 | 0.80 | 0.20 | 0.30 | 0.30 | -0.06 | -0.29 | -0.85 | 0.40 | 0.23 | -0.02 | -0.51 | -0.09 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 2.21M | 2.21M | 2.21M | 2.22M | 2.22M | 2.22M | 2.20M | 2.19M | 2.15M | 2.04M | 2.02M | 2.01M | 2.00M | 1.86M | 1.40M | 1.39M | 1.39M | 1.39M | 1.39M | 1.35M | 2.97M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 2.21M | 2.21M | 2.21M | 2.22M | 2.22M | 2.22M | 2.24M | 2.19M | 2.28M | 2.22M | 2.20M | 2.15M | 2.10M | 1.89M | 1.40M | 1.39M | 1.39M | 1.39M | 1.39M | 1.35M | 2.97M |
Source: https://incomestatements.info
Category: Stock Reports